Gene · 8742
Papers2,943
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,943
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Decoding meningioma heterogeneity and neoplastic cell-macrophage interaction through single-cell transcriptome profiling across pathological grades. | J Transl Med | 2023 | 37880655 | PubTator, text mining | PubMed |
| Mononuclear cells from patients with rhupus are influenced by TNF in their production of gp130/sIL-6Rb and APRIL. | Lupus Sci Med | 2023 | 37880158 | PubTator, text mining | PubMed |
| Transcriptome analysis reveals molecular mechanisms of lymphocystis formation caused by lymphocystis disease virus infection in flounder (Paralichthys olivaceus). | Front Immunol | 2023 | 37868974 | PubTator, text mining | PubMed |
| High RIPK3 expression is associated with a higher risk of early kidney transplant failure. | iScience | 2023 | 37868627 | PubTator, text mining | PubMed |
| Advances in understanding and treating diabetic kidney disease: focus on tubulointerstitial inflammation mechanisms. | Front Endocrinol (Lausanne) | 2023 | 37859992 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis reveals a systemic immune dysregulation in COVID-19-associated pediatric encephalopathy. | Signal Transduct Target Ther | 2023 | 37848421 | PubTator, text mining | PubMed |
| Effect of Continuous Ingestion of Bifidobacteria and Dietary Fiber on Improvement in Cognitive Function: A Randomized, Double-Blind, Placebo-Controlled Trial. | Nutrients | 2023 | 37836458 | PubTator, text mining | PubMed |
| Clinical Significance of Extracellular Vesicles in Prostate and Renal Cancer. | Int J Mol Sci | 2023 | 37834162 | PubTator, text mining | PubMed |
| Lupus Nephritis Risk Factors and Biomarkers: An Update. | Int J Mol Sci | 2023 | 37833974 | PubTator, text mining | PubMed |
| TWEAK Progress in Dermatology: A Review. | Indian J Dermatol | 2023 | 37822396 | PubTator, text mining | PubMed |
| Ectodysplasin A2 receptor-NF-κB-inducing kinase axis: a new player in muscle wasting to cancer cachexia. | Signal Transduct Target Ther | 2023 | 37807033 | PubTator, text mining | PubMed |
| CIRCULATING PEPTIDES OF THE TNF SUPERFAMILY AND TNF RECEPTOR SUPERFAMILY IN SUBJECTS WITH TYPE 1 DIABETES: RELATIONSHIPS WITH CLINICAL AND METABOLIC PARAMETERS. | Georgian Med News | 2023 | 37805905 | PubTator, text mining | PubMed |
| Evaluating the prevalence of inborn errors of immunity in adults with chronic immune thrombocytopenia or Evans syndrome. | Blood Adv | 2023 | 37792884 | PubTator, text mining | PubMed |
| Role of growth differentiation factor 15 in cancer cachexia (Review). | Oncol Lett | 2023 | 37780545 | PubTator, text mining | PubMed |
| Is there a role in acute kidney injury for FGF23 and Klotho? | Clin Kidney J | 2023 | 37779849 | PubTator, text mining | PubMed |
| Targeting the TWEAK-Fn14 pathway prevents dysfunction in cardiac calcium handling after acute kidney injury. | J Pathol | 2023 | 37776271 | PubTator, text mining | PubMed |
| Chronic Diarrhea with Villous Blunting of the Small Intestine Under Capsule Endoscopy in Common Variable Immunodeficiency and X-Linked Agammaglobulinemia: A Case Series. | J Asthma Allergy | 2023 | 37772267 | PubTator, text mining | PubMed |
| A Route for Investigating Psoriasis: From the Perspective of the Pathological Mechanisms and Therapeutic Strategies of Cancer. | Int J Mol Sci | 2023 | 37762693 | PubTator, text mining | PubMed |
| Pathway from Acute Kidney Injury to Chronic Kidney Disease: Molecules Involved in Renal Fibrosis. | Int J Mol Sci | 2023 | 37762322 | PubTator, text mining | PubMed |
| A549 as an In Vitro Model to Evaluate the Impact of Microplastics in the Air. | Biology (Basel) | 2023 | 37759642 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8742/papers?page=19